Navigation Links
Neogen Launches Quickest Test Available for Tetracyclines in Milk

LANSING, Mich., Feb. 13 /PRNewswire-FirstCall/ -- Neogen Corporation (Nasdaq: NEOG) has expanded its line of products developed for the dairy industry to include the quickest test available for tetracycline residues in milk. The tetracyclines group of dairy antibiotics is used to treat bovine mastitis, and includes tetracycline, chlortetracycline, and oxytetracycline.

Neogen's new TetraStar(R) dairy antibiotic test for tetracyclines complements the company's widely used BetaStar(R) test for the beta-lactam group of dairy antibiotics, which includes amoxicillin, ampicillin, cephapirin, cloxacillin, and penicillin. TetraStar produces clear results in a market-best six minutes, and like BetaStar, is an extremely simple dipstick test that requires only minimal training and equipment to produce consistently accurate results.

"As tetracyclines have emerged as a second choice of antibiotics to beta- lactams for the management of mastitis in dairy herds in certain regions of the world, the concern over tetracycline drug residues in milk has grown," said Lon Bohannon, Neogen's president. "Developing TetraStar allows us to offer the worldwide dairy industry yet another simple solution to protect its consumers and businesses. Two years ago when we acquired the dairy antibiotics business from UCB, including its popular BetaStar line, we did so with the idea of expanding the business by introducing new products based on market demand. Launching TetraStar today is yet another example of our commitment to supply innovative products to help meet our customers' needs."

Because the tetracyclines group of dairy antibiotics is not yet used as universally as the beta-lactam group, regulations governing the maximum allowable levels of tetracyclines in milk are not as widespread. As the European Union has set a maximum residue level of 100 parts per billion for tetracyclines in milk, Neogen expects the strongest initial interest for its TetraStar product from EU countries, and especially Spain, where tetracyclines are more widely used.

The worldwide market for antibiotic testing of milk has been estimated to exceed $60 million. A significant portion of that total market is in the United States, where virtually every load of raw milk delivered to dairy processing plants is tested for antibiotic residues.

In addition to its growing line of dairy antibiotic tests, Neogen's Food Safety Division also offers the dairy industry: rapid milk allergen tests that allow multipurpose production lines to be tested quickly and reliably following the sanitation process; rapid foodborne pathogen and indicator organism tests to ensure product safety and quality; and an unequaled sanitation monitoring system that puts the speed and convenience of ATP testing in a lightweight, rugged instrument that fits in the palm of one's hand. Neogen's Animal Safety Division also offers the dairy industry a wide variety of offerings, including a comprehensive line of hoof care and obstetrical products.

Neogen Corporation develops and markets products dedicated to food and animal safety. The company's Food Safety Division markets dehydrated culture media, and diagnostic test kits to detect foodborne bacteria, natural toxins, genetic modifications, food allergens, drug residues, plant diseases and sanitation concerns. Neogen's Animal Safety Division markets a complete line of diagnostics, veterinary instruments, veterinary pharmaceuticals, nutritional supplements, disinfectants, and rodenticides.

SOURCE Neogen Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Neogen Reports 34% Increase in Net Income, 23% Increase in Revenues
2. Neogen Acquires Assets of Rivard Instruments
3. Neogen Reports 25% Increase in Net Income, 13% Increase in Revenues
4. Neogen Acquires Kane Enterprises
5. Lucid Launches VivaNet(R) Telemedicine Server for Dermatology Applications
6. Arobella Medical, LLC Launches Qoustic Wound Therapy System(TM)
7. Barr Launches Generic Fosamax(R) Tablets, 70 mg
8. NHS Choices Launches New BMI Calculator
9. Oncothyreon launches new corporate website
10. Blue Cross and Blue Shield of Texas Launches an Integrated Medical-Dental Health Program
11. Arryx Launches HOTkit(TM) Complete for Dynamic, Scientific Manipulation of Microscopic Elements
Post Your Comments:
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... to bring innovative medical technologies, services and solutions to the healthcare market. The ... implementation of various distribution, manufacturing, sales and marketing strategies that are necessary to ...
(Date:6/24/2016)... , June 24, 2016 Epic ... sensitively detects cancers susceptible to PARP inhibitors by ... tumor cells (CTCs). The new test has already ... therapeutics in multiple cancer types. Over ... DNA damage response pathways, including PARP, ATM, ATR, ...
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
(Date:6/23/2016)...  The Prostate Cancer Foundation (PCF) is pleased to announce 24 ... for prostate cancer. Members of the Class of 2016 were selected from a ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
Breaking Biology Technology:
(Date:5/9/2016)... , UAE, May 9, 2016 ... when it comes to expanding freedom for high net ... Even in today,s globally connected world, there is ... conferencing system could ever duplicate sealing your deal with ... obtaining second passports by taking advantage of citizenship via ...
(Date:4/26/2016)... LONDON , April 26, 2016 ... EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... a partnership to integrate the Onegini mobile security ... (Logo: ) The ... enhanced security to access and transact across channels. ...
(Date:4/15/2016)... 15, 2016 Research and ... Biometrics Market 2016-2020,"  report to their offering.  , ... , ,The global gait biometrics market is expected ... the period 2016-2020. Gait analysis generates ... be used to compute factors that are not ...
Breaking Biology News(10 mins):